Simone Krebs Laboratory

The Illustrated Post: Symptomatic PSMA PET–positive radionecrosis after multimodality brain metastasis–directed treatment including ¹⁷⁷Lu-PSMA-617. ow.ly/5sra50Vjv05 #RPTherapy #NuclearMedicine #BrainMetastases @LabKrebs @brandon_imber @mskCancerCenter

@lab_rezvani Congratulations!

Deep gratitude to MDACC leadership and Board of Visitors, my incredible team, our collaborators, and everyone who joined us for today’s launch of the Institute for Cell Therapy Discovery and Innovation. Your support and belief in our vision inspire us to push the boundaries of cell therapy research. Read more: brnw.ch/21wOup7 #EndCancer @MDAndersonNews #CellTherapy #Institute

Join the European Molecular Imaging Meeting, March 11-14, 2025 in Bilbao, ES! Submissions are already possible with deadline 19 November 2024. We can't wait to see you next spring in beautiful Bilbao!

Submit your abstract for #WMIC2024 and be considered for prestigious awards that recognize your work and support your attendance! 🏆 Young Investigator: Up to $2,000 ✈️ Travel Stipends: Up to $800 🖼️ Poster Awards: $250 🔬 Interest Group Awards Details: wmis.org/wmic-2024-abou…

@LewisLabMSKCC @MSKCancerCenter I am truly humbled and honored to receive this esteemed award. And I greatly appreciate the support and encouragement that I have received from my mentors, colleagues and team members throughout my endeavors.

Dr. Simone Krebs @LabKrebs winning the Saul Hertz Young Investigator Award at Theranostics 2024. @MSKCancerCenter #theranostics #TWC2014

Our latest article in @JournalofNucMed reviewing the role of nuclear imaging approaches for improved diagnosis of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. @StanfordMIPS, @FedeSimonetta

Dear Colleagues, the abstract system has been just re-opened for late-breaking submissions to the EMIM meeting in Porto – with deadline on Thursday 25 January 2024! Don't miss this last chance and/or encourage your colleagues to submit. Just proceed to emim.eu.

Dear Colleagues, In my capacity as Program Chair, I would like to bring the upcoming EMIM 2024 to your attention: The deadline for abstract submission is 21 November 2023 via emim.eu. We can't wait to see you next spring in beautiful Porto!

Our paper is out! We present a versatile platform enabling monitoring of CAR-T cells in vivo using PET, as well as providing selective delivery of therapeutic radioisotopes to increase anti-tumor efficacy. Great team work! @DASLab_MSKCC thno.org/v13p5469.htm #Theranostics

Leah Gajecki giving an amazing talk about her work on novel 161Tb DOTA haptens! #WMIC 2023

⁶⁸Ga-pentixafor PET may guide CXCR4-based theranostic approaches with pentixather in selected #meningioma. ow.ly/bZKY50NAtB9 #PETscan #Theranostics @LabKrebs

Using blood-based #biomarkers to determine the efficacy of ¹⁷⁷Lu-DOTATATE in #NeuroendocrineTumors. ow.ly/4PAF50NAttU #NuclearMedicine #MedicalResearch #NETCancer @lisabodei @DianeReidyLagun @LabKrebs @amauguen @DrRichardDo

@LabKrebs We have an open postdoc position. Are you interested in molecular imaging and therapy (theranostic) and adoptive T cell therapy? Motivated to work in a highly interactive, interdisciplinary and rewarding environment? Then check us out! mskcc.org/research-areas…

@LabKrebs Huge congratulations to Laura Eibler for receiving the 1st Place price in Basic Track for her abstract & 1st Place Center for Molecular Imaging Innovation & Translation Young Investigator Award at the SNMMI 2022!! And kudos to the entire team! @DASLab_MSKCC Larson Lab

Fantastic talk by @emma_reynaud99 wrapping up months of amazing work imaging CAR T cells in action diagnosing & treating cancers @MSKCancerCenter @LabKrebs @DASLab_MSKCC @SchuringaJan Larsonlab #theranostics